Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.
An opinion piece highlights the growing concerns among medical professionals about the exacerbating effects the COVID-19 pandemic may have among people with opioid use disorder.
Opioid-related deaths in the cancer population are much rarer than in the general population.
Financial incentives improved X-waiver training completion and buprenorphine prescribing rates in emergency department physicians.
The in-hospital mortality for native valve infective endocarditis has decreased between 2002 and 2016.
Compared with nonsteroidal anti-inflammatory drugs, opioids are more likely to result in adverse kidney outcomes and death, a study found.
In parallel to the ongoing national opioid crisis, the incidence rate of infective endocarditis cases has increased markedly among people aged 18 to 29 years with hepatitis C virus infection and those with opioid use disorder.
Despite conflicting evidence, a third of primary physicians do not perceive OUD medication to be more effective than nonmedication treatment.
Compared with all opioid prescriptions, a higher hydromorphone controlled-release dispensing rate was a strong predictor of hepatitis C virus incidence.
People who receive additional treatment following medically managed opioid withdrawal have reduced mortality.